Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer International Publishing
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519630/ |